tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market
Holding RLAY?
Track your performance easily

Relay Therapeutics (RLAY) Cash flow

405 Followers

Relay Therapeutics Cash Flow

RLAY's free cash flow for Q3 2024 was $-75.31M. For the 2024 fiscal year, RLAY's free cash flow was decreased by $-65.89M and operating cash flow was $-75.08M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -280.43M$ -300.32M$ -229.49M$ -74.41M$ -102.49M$ -66.13M
Investing Cash Flow
$ -10.40M$ 257.63M$ -188.75M$ -479.51M$ 81.67M$ -319.02M
Financing Cash Flow
$ 291.27M$ 34.75M$ 289.91M$ 388.09M$ 426.51M$ 5.61M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 593.32M$ 146.44M$ 154.37M$ 282.70M$ 448.52M$ 42.83M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--$ 1.69M$ 1.14M$ 426.51M$ 5.61M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -193.26M$ -304.44M$ -238.55M$ -77.88M$ -104.42M$ -74.14M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Relay Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis